Keck School of Medicine of USC
We are dedicated to promoting health, preventing and curing disease, advancing biomedical research and educating tomorrow’s physicians and scientists.
New Data Show Pertuzumab + Trastuzumab + Chemo Continue Yielding Clinical Benefit / Adjuvant T-DM1 Benefit in HER2+ Early BC
Login to view comments.
Click here to Login